Owyang et al., 1983 - Google Patents
Colonic inhibition of pancreatic and biliary secretionOwyang et al., 1983
- Document ID
- 14643772858878451114
- Author
- Owyang C
- Green L
- Rader D
- Publication year
- Publication venue
- Gastroenterology
External Links
Snippet
The purpose of this study was to determine whether or not nutrients in the colon influence pancreatic and biliary secretion in humans. In six healthy subjects, similar caloric loads (117 cals) of oleic acid, essential amino acids, and glucose in isomolar (280 mosmol/L), similar …
- 230000028327 secretion 0 title abstract description 44
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Owyang et al. | Colonic inhibition of pancreatic and biliary secretion | |
Malagelada et al. | Interactions between intraluminal bile acids and digestive products on pancreatic and gallbladder function | |
Sandle | Salt and water absorption in the human colon: a modern appraisal | |
Sherwin et al. | Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon | |
Dworkin et al. | Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition | |
Rambaud et al. | Pancreatic cholera: studies on tumoral secretions and pathophysiology of diarrhea | |
DenBesten et al. | The different effects on the serum lipids and fecal steroids of high carbohydrate diets given orally or intravenously | |
Dutta et al. | Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine | |
Thompson et al. | Action of neomycin on the intraluminal phase of lipid absorption | |
Zentler-Munro et al. | Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. | |
Longstreth et al. | Postprandial gastric, pancreatic, and biliary response to histamine H2-receptor antagonists in active duodenal ulcer | |
Muller et al. | Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs: a quantitative assessment of secretion rates and anatomical delineation of sources | |
You et al. | Effects of atropine on the action and release of secretin in humans | |
Owyang et al. | Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and in chronic pancreatitis | |
Spira et al. | Factors contributing to the degree of polyuria in a patient with poorly controlled diabetes mellitus | |
Jeevanandam et al. | Cancer cachexia and the rate of whole body lipolysis in man | |
Taylor | Role of peptide YY in the endocrine control of digestion | |
JPH08502039A (en) | Compositions and methods for reducing muscle deterioration | |
Koide et al. | Role of endogenous bile on basal and postprandial CCK release in humans | |
Guan et al. | Peptide-YY, a new partner in the negative feedback control of pancreatic secretion | |
OWYANG et al. | Evidence for modulation of motilin secretion by pancreatico-biliary juice in health and in chronic pancreatitis | |
Shey et al. | Recurrent calcium nephrolithiasis associated with primary aldosteronism | |
Li et al. | Effect of pancreatic proteases on plasma cholecystokinin, secretin, and pancreatic exocrine secretion in response to sodium oleate | |
Weber Jr et al. | Effects of Branched–Chain Amino Acids on Nitrogen Metabolism in Patients With Cirrhosis | |
Olesen et al. | Importance of Colonic Bacterial Fermentation in Short Bowel Patients (Small Intestinal Malabsorption of Easily Digestible Carbohydrate) |